Completely "Industrialized"! AI Triggers a Revolution in Biopharmaceuticals
A16Z 生物基金創始投資者 Vijay Pande 表示，生命科學正在實現工業化。在 AI 的助力下，藥物的研發不再依靠偶然性，而是能夠被精準把控。
在 A16Z 生物基金主辦的 “BUILD 2024” 峯會上，A16Z 創始投資者 Vijay Pande 表示，生命科學正在實現工業化。
而工業化之所以倍受青睞，是因為它代表着持續的、隨着時間推移而實現複利增長。
這意味着在 AI 的助力下，藥物的研發不再依靠偶然性，而是能夠被精準把控，因此整個生物學正在發生徹底變革。
Source: 華爾街見聞 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments